INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:INSP - US4577301090 - Common Stock
124.41 USD
-2.92 (-2.29%)
124.41 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 74% to INSP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 113.99. This target is -8.38% below the current price.
INSP was analyzed by 26 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about INSP.
In the previous month the buy percentage consensus was at a similar level.
INSP was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-26 | Truist Securities | Upgrade | Hold -> Buy |
| 2025-11-25 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2025-11-24 | Stifel | Upgrade | Hold -> Buy |
| 2025-11-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-04 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-11-04 | Truist Securities | Reiterate | Hold -> Hold |
| 2025-11-04 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-04 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-10-24 | Jefferies | Downgrade | Buy -> Hold |
| 2025-10-15 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-22 | UBS | Downgrade | Buy -> Neutral |
| 2025-09-02 | Evercore ISI Group | Initiate | Outperform |
| 2025-08-15 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2025-08-05 | Lake Street | Maintains | Buy -> Buy |
| 2025-08-05 | UBS | Maintains | Buy -> Buy |
| 2025-08-05 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-08-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-05 | Stifel | Maintains | Hold -> Hold |
| 2025-08-05 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-05 | Truist Securities | Downgrade | Buy -> Hold |
| 2025-08-05 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-08-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-22 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-07-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-06 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-21 | Keybanc | Maintains | Overweight -> Overweight |
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What do analysts expect the price target to be for INSPIRE MEDICAL SYSTEMS INC (INSP)?
26 analysts have analysed INSP and the average price target is 113.99 USD. This implies a price decrease of -8.38% is expected in the next year compared to the current price of 124.41.
What is the consensus rating for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The consensus rating for INSPIRE MEDICAL SYSTEMS INC (INSP) is 73.8462 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for INSP stock?
The number of analysts covering INSPIRE MEDICAL SYSTEMS INC (INSP) is 26.